Manifold MarketsSin KYCDatos de resolución verificadosCalibración aceptablePronóstico comunitario actualPortugal 94%Líder entre 13 opciones
Pronosticadores
17
Tipo de pregunta
multiple choice
Metodología
Play-money forecasting platform
Tipo de fuente
Pronóstico
Cambio 7d
0.0 pts
Datos de mercado
Actualizado hace 17 horas
Desactualizado27 mar 24, 19:24 UTC31 dic 29, 22:59 UTC
Tendencias
Reglas
This market resolves Yes to each country that legalizes the use of one or more psychedelic substances between market creation and market close, including cases in which such use is contingent on prescription by a licensed medical professional.
- At the time of market creation, studies on the efficacy of psychedelic substances in mental health treatments are being conducted by various institutes globally.
- Several countries have shown interest in exploring the therapeutic potential of psychedelics, with promising results emerging in the treatment of addiction, schizophrenia, depression, and other disorders.
- Some of the countries listed as options already allow the use of some psychedelics in some or all settings.
- For example, Australia has legalized the prescription of MDMA and psylocibin effective Jul 1, 2023.
- In Germany, ibogaine is legal while other psychedelics remain illegal.
